Stocks Overview

LAST PRICE
42.2600
TODAY'S CHANGE (%)
Trending Down-0.9600 (-2.2212%)

Bid / Lots
42.0900/ 1
Ask / Lots
42.2600/ 10
Open / Previous Close
43.1000 / 43.2200
Day Range
Low 42.1800
High 43.1700
52 Week Range
Low 4.8250
High 50.7800
Volume
854,008
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 43.22
Time	Volume	RNA
09:32 ET	12200	42.7
09:34 ET	4863	42.345
09:36 ET	2873	42.655
09:38 ET	250	42.63
09:39 ET	2131	42.6312
09:41 ET	200	43.115
09:43 ET	983	43.105
09:45 ET	902	42.99
09:48 ET	9677	43.01
09:50 ET	3058	42.79
09:52 ET	800	42.91
09:54 ET	1000	42.78
09:56 ET	2273	42.64
09:57 ET	3609	42.3
09:59 ET	947	42.37
10:01 ET	2225	42.291
10:03 ET	3374	42.295
10:06 ET	2157	42.4626
10:08 ET	487	42.71
10:10 ET	1718	42.61
10:14 ET	800	42.76
10:15 ET	3097	42.75
10:17 ET	300	42.86
10:19 ET	2500	42.94
10:21 ET	400	42.975
10:24 ET	300	43.005
10:26 ET	1406	42.97
10:28 ET	750	42.935
10:30 ET	1200	42.92
10:32 ET	1513	42.71
10:33 ET	1000	42.86
10:35 ET	100	42.79
10:37 ET	720	42.78
10:39 ET	1200	42.765
10:42 ET	2612	42.735
10:44 ET	1932	42.57
10:46 ET	813	42.63
10:48 ET	100	42.59
10:50 ET	3500	42.44
10:51 ET	700	42.32
10:53 ET	200	42.42
10:55 ET	598	42.4
10:57 ET	1338	42.42
11:00 ET	820	42.44
11:02 ET	300	42.375
11:04 ET	2191	42.39
11:06 ET	4288	42.3782
11:08 ET	700	42.335
11:09 ET	120	42.41
11:11 ET	200	42.365
11:13 ET	6647	42.42
11:15 ET	840	42.54
11:18 ET	2620	42.6
11:20 ET	2100	42.66
11:22 ET	2013	42.73
11:24 ET	651	42.77
11:26 ET	1867	42.66
11:27 ET	1183	42.58
11:29 ET	500	42.71
11:31 ET	200	42.63
11:33 ET	311	42.58
11:36 ET	560	42.7
11:40 ET	200	42.715
11:42 ET	460	42.71
11:44 ET	200	42.72
11:45 ET	700	42.705
11:47 ET	100	42.705
11:49 ET	237	42.705
11:51 ET	1000	42.685
11:54 ET	300	42.685
11:56 ET	718	42.57
11:58 ET	1000	42.655
12:02 ET	2516	42.77
12:03 ET	1420	42.905
12:05 ET	2454	42.86
12:07 ET	600	42.92
12:09 ET	1783	42.94
12:12 ET	400	42.92
12:14 ET	700	42.935
12:16 ET	1129	42.89
12:18 ET	100	42.89
12:20 ET	300	42.895
12:21 ET	522	42.935
12:23 ET	600	42.915
12:25 ET	200	42.89
12:27 ET	505	42.79
12:30 ET	200	42.78
12:32 ET	1825	42.855
12:34 ET	941	42.95
12:36 ET	1005	42.84
12:38 ET	600	42.76
12:41 ET	100	42.725
12:43 ET	400	42.725
12:45 ET	100	42.71
12:48 ET	800	42.66
12:50 ET	1794	42.59
12:52 ET	200	42.57
12:54 ET	5145	42.55
12:56 ET	1300	42.635
12:57 ET	2031	42.57
12:59 ET	725	42.59
01:01 ET	314	42.6
01:03 ET	950	42.685
01:06 ET	300	42.67
01:08 ET	900	42.675
01:10 ET	1652	42.625
01:12 ET	911	42.74
01:14 ET	1336	42.55
01:15 ET	1300	42.68
01:17 ET	104	42.66
01:19 ET	300	42.79
01:21 ET	459	42.7401
01:24 ET	1533	42.86
01:26 ET	1253	42.795
01:28 ET	400	42.81
01:30 ET	1333	42.65
01:32 ET	700	42.57
01:33 ET	1727	42.62
01:35 ET	1099	42.67
01:37 ET	500	42.605
01:39 ET	100	42.6
01:42 ET	100	42.605
01:44 ET	4000	42.63
01:46 ET	932	42.63
01:48 ET	1958	42.61
01:51 ET	1000	42.65
01:53 ET	100	42.66
01:55 ET	1500	42.7
01:57 ET	1561	42.69
02:00 ET	1900	42.81
02:02 ET	3165	42.93
02:04 ET	3899	42.95
02:06 ET	965	42.95
02:08 ET	400	42.945
02:09 ET	651	42.955
02:11 ET	2465	42.99
02:13 ET	3640	42.7
02:15 ET	1000	42.83
02:18 ET	400	42.725
02:20 ET	1782	42.62
02:22 ET	1599	42.67
02:24 ET	633	42.625
02:26 ET	734	42.62
02:27 ET	2039	42.65
02:29 ET	2541	42.575
02:31 ET	700	42.61
02:33 ET	1102	42.69
02:36 ET	1194	42.67
02:38 ET	2523	42.69
02:40 ET	1303	42.7
02:42 ET	100	42.655
02:44 ET	815	42.6527
02:45 ET	600	42.71
02:47 ET	500	42.69
02:49 ET	400	42.69
02:51 ET	3243	42.68
02:54 ET	2600	42.76
02:56 ET	3389	42.76
02:58 ET	300	42.76
03:00 ET	2064	42.77
03:02 ET	2845	42.79
03:03 ET	664	42.77
03:05 ET	1000	42.76
03:07 ET	1004	42.81
03:09 ET	800	42.885
03:12 ET	400	42.94
03:14 ET	200	42.88
03:16 ET	1100	42.94
03:18 ET	2334	42.897
03:20 ET	5008	42.865
03:21 ET	1000	42.87
03:23 ET	1000	42.83
03:25 ET	1210	42.85
03:27 ET	3186	42.84
03:30 ET	400	42.81
03:32 ET	2100	42.865
03:34 ET	900	42.85
03:36 ET	2000	42.825
03:38 ET	1524	42.79
03:39 ET	1500	42.81
03:41 ET	3723	42.84
03:43 ET	756	42.84
03:45 ET	1016	42.895
03:48 ET	4468	42.875
03:50 ET	42361	42.82
03:52 ET	5953	42.75
03:54 ET	17739	42.58
03:56 ET	11078	42.33
03:57 ET	12665	42.365
03:59 ET	208179	42.26

Data delayed at least 15 minutes.

Today
- Avidity Biosciences to Host Investor and Analyst Event Focused on Precision Cardiology Candidates and First Look at Next-Generation Technology Innovations on November 12, 2024, from 12 hours ago by Dow Jones
  12 hours ago by Dow Jones
- DJ Avidity Biosciences Price Target Maintained With a $60.00/Share by Needham, from 15 hours ago by Dow Jones
  15 hours ago by Dow Jones
Yesterday
- DJ Avidity Biosciences Is Maintained at Buy by Chardan Capital, from 9:36AM ET on Wednesday Oct 30, 2024 by Dow Jones
  9:36AM ET on Wednesday Oct 30, 2024 by Dow Jones
- Avidity Biosciences Pursues Potential Accelerated Approval Path with Initiation of Biomarker Cohort in FORTITUDE(TM) Trial for Delpacibart Braxlosiran (del-brax/AOC 1020) in People Living with Facioscapulohumeral Muscular Dystrophy, from 8:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
  8:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
Oct 21, 2024
- Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Monday Oct 21, 2024 by Dow Jones
  4:05PM ET on Monday Oct 21, 2024 by Dow Jones

1 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRNA Avidity Biosciences Inc	5.0B	-14.3x	---
United StatesCRNX Crinetics Pharmaceuticals Inc	5.0B	-14.9x	---
United StatesBHVN Biohaven Ltd	5.0B	-5.4x	---
United StatesKRYS Krystal Biotech Inc	5.0B	47.2x	---
United StatesMDGL Madrigal Pharmaceuticals Inc	4.7B	-10.2x	---
United StatesBBIO BridgeBio Pharma Inc	4.5B	-8.9x	---
As of 2024-10-31

Avidity Biosciences, Inc. is a biopharmaceutical company. The Company is engaged in delivering a new class of ribonucleic acid (RNA) therapeutics called antibody oligonucleotide conjugates (AOCs). The AOCs are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to address targets and diseases previously unreachable with existing RNA therapies. Its advancing and expanding pipeline has three programs in clinical development. AOC 1001 is designed to treat people with myotonic dystrophy type 1 (DM1) and is in phase I/II development with the ongoing MARINA open label extension study (MARINA-OLE). AOC 1044 is designed for people with Duchenne muscular dystrophy and is in phase I/II development with the EXPLORE44 trial. AOC 1020 is designed to treat people living with facioscapulohumeral muscular dystrophy (FSHD) and is in Phase I/II development with the FORTITUDE trial.

Contact Information

Headquarters: 10578 SCIENCE CENTER DRIVE, SUITE 125SAN DIEGO, CA, United States 92121
Phone: 858-401-7900
Fax: 302-636-5454

Executives

Non-Executive Independent Chairman of the Board: Troy Wilson
President, Chief Executive Officer, Director: Sarah Boyce
Chief Financial and Chief Business Officer: Michael Maclean
Chief Human Resource Officer: Teresa Mccarthy
Chief Scientific and Technical Officer: W. Michael Flanagan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$5.0B
Revenue (TTM)	$10.6M
Shares Outstanding	116.6M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.89
EPS	$-2.95
Book Value	$6.32
P/E Ratio	-14.3x
Price/Sales (TTM)	475.4
Price/Cash Flow (TTM)	---
Operating Margin	-2,690.64%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Avidity Biosciences Inc
NASDAQ:RNAUnited States

Search Criteria

Charts

Recent News

Today

Avidity Biosciences to Host Investor and Analyst Event Focused on Precision Cardiology Candidates and First Look at Next-Generation Technology Innovations on November 12, 2024, from 12 hours ago by Dow Jones

DJ Avidity Biosciences Price Target Maintained With a $60.00/Share by Needham, from 15 hours ago by Dow Jones

Yesterday

DJ Avidity Biosciences Is Maintained at Buy by Chardan Capital, from 9:36AM ET on Wednesday Oct 30, 2024 by Dow Jones

Avidity Biosciences Pursues Potential Accelerated Approval Path with Initiation of Biomarker Cohort in FORTITUDE(TM) Trial for Delpacibart Braxlosiran (del-brax/AOC 1020) in People Living with Facioscapulohumeral Muscular Dystrophy, from 8:00AM ET on Wednesday Oct 30, 2024 by Dow Jones

Oct 21, 2024

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Monday Oct 21, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar